MedicaidCoverageHigh impact
Effective November 30, 2026: Clinical Policies
Ambetter·TX · Oncology, Orthopedics, Pain Management +4 more·Provider Bulletin
Effective date
Nov 30, 2026
We identified it
Sep 18, 2026
Summary
Ambetter Health and Superior HealthPlan updated six clinical policies effective November 30, 2026, including new coverage for hematopoietic cell therapy (TREGZI), revised DME coverage removing ankle-foot orthotics and lower extremity prosthetics while adding external sensory prosthetic devices, stricter criteria for sacroiliac joint and nerve root block interventions, and a new policy establishing medical necessity for skin substitute grafts in diabetic foot and venous leg ulcers. Billing teams must immediately identify affected claims and update authorization workflows before the November effective date.
Action Required
By November 30, 2026: (1) Billing team must immediately remove CPT 54163 from non-covered/cosmetic procedure denials and update systems to recognize it as covered repair procedure under Cosmetic and Reconstructive Procedures policy for Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS) and CHIP; (2) Update DME billing rules to DENY claims for HCPCS codes L1933, L1952 (ankle-foot orthotics) and L8030, L8035 (lower extremity prosthetics) and add documentation that these are no longer covered; (3) Add new coverage pathway for L8720, L8721 (External Lower Extremity Sensory Prosthetic Device/Walkasins®) with notation 'not medically necessary—insufficient evidence' to prevent accidental approvals; (4) For all sacroiliac joint intervention claims, implement new criteria requiring documentation of 12-month injection history before advanced consideration per CP.MP.166; (5) For selective nerve root blocks (CP.MP.165), update authorization templates to: restrict SNRB to diagnostic purposes only, require four-week (not three-day) interval documentation, add imaging correlation requirement, and remove all references to cervical TFESI non-particulate steroid mandates and real-time imaging requirements that have been deleted; (6) Implement new skin substitute/CTP authorization pathway requiring prior auth for Q4101, Q4102, Q4104, Q4105, Q4121, Q4132, Q4133, Q4158, Q4186 with mandatory documentation of: specific wound location, >1 cm² size, 50% area reduction failure after 4 weeks standard of care (for DFU) or failure to respond with 4 weeks SOC (for VLU), updated HbA1c/glucose/compression documentation, weekly measurements, and smoking status; (7) Providers must update encounter templates and prior authorization request forms to capture new documentation requirements; (8) Send communication to all providers explaining changes; (9) Train billing staff on new criteria before November 30 to prevent claim denials for missing documentation. Failure to implement will result in increased denials for non-compliant claims and authorization delays.